Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQInformation TechnologySoftware - InfrastructureSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for XBP yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
20% reduction in global headcount by end of 2026 | XBP is cutting costs by reducing its global workforce by 20% by end of 2026. | Intact | headcount reduction falls short of 20% by end of 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative turnaround thesis, not a proven durable compounder. The current thesis state is watch: financial performance is neutral, but the company remains loss-making and recent quality and management measures have weakened.
The evidence snapshot provides no valuation comparison or clear account of market expectations, so whether XBP is cheap or expensive versus peers is unclear. The recent share-price reaction was up, but that alone does not show what expectations are priced in.
Near term, earnings risk is elevated after recent misses, and management volatility adds uncertainty. For the multi-year view, management is aiming for $65 million to $75 million in annualized operational efficiencies, including about $35 million of benefit in 2026, but progress is mixed; the planned headcount reduction and exploration of strategic alternatives also lack clear outcome measures so far.
The central swing factor is whether management delivers the efficiency plan without reversing its recently raised guidance, which would further damage credibility. Near term, Fed rate cuts or stabilization among major technology companies could support the sector backdrop, but the evidence does not establish how much this would affect XBP specifically.
Over the next one to three years, the thesis depends on measurable cost savings, steadier execution, and clearer results from the strategic review. Losses, elevated earnings risk, and weaker management and quality measures keep the evidence uncertain. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in XBP GLOBAL HOLDINGS INC's published investment case. The stated target is No further adverse credit amendments or defaults. |
| Improving |
| new adverse credit amendments or defaults occur |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Address earnings miss and improve earnings | The company is addressing its recent earnings miss and managing credit agreements to stabilize finances. | Broken | EPS loss worsens beyond -4.51 in FY26 or fails to improve in FY27 | Diluted EPS: $-1.42 per share FY2026-Q2; GAAP. Published target: reduce EPS loss from -4.51 in 2026 to less negative in 2027. Annual target cannot be compared with a quarterly or TTM observation. Aug 14, 2026-1.42 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth from $220M in 2025 to $810M in 2026 | A primary condition in XBP GLOBAL HOLDINGS INC's published investment case. The stated target is >=$810 million revenue. | Broken | revenue falls below $810 million in FY26 | Revenue: $191.311M FY2026-Q2; GAAP. Published target: >=$810 million revenue. Annual target cannot be compared with a quarterly or TTM observation. Aug 14, 2026191,311,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-1.51 → $-1.51 · observed estimates
$0.90B → $0.90B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-07-25 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-07-26 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-07-27 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-07-28 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-07-29 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-07-30 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-07-31 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-01 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-02 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-03 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-04 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-05 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-06 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-08 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-09 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-10 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-12 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-13 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-14 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-15 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-16 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-17 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-18 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-19 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-20 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-21 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-22 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-23 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-24 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-25 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-26 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-27 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-28 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-29 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-30 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-08-31 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-01 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-02 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-03 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-04 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-05 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-06 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-07 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-08 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-09 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-10 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-11 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-12 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-13 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-14 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-15 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-16 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-17 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-18 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-19 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-20 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-21 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-22 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-23 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-24 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-25 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-26 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-27 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-28 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-29 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-09-30 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-01 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-02 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-03 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-04 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-05 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-06 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-07 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-08 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-09 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-10 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-11 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-12 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-13 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-14 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-15 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-16 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-17 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-18 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-19 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-20 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-21 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-22 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-23 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-24 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-25 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-26 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-27 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-28 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-29 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-30 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-10-31 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-11-01 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-11-02 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-11-03 | $-1.51 | $898,600,000 | 1 / 1 |
| 2026-11-04 | $-1.51 | $898,600,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 13, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.